The AMR Policy Accelerator addresses AMR policy research gaps and supports effective global and national policymaking with the ultimate aim of sustainable antimicrobial use for everyone. We incorporate a One Health approach by bringing together academics, civil society actors and policymakers from all sectors for a diverse set of perspectives on AMR. We are committed to integrating equity considerations in our advisory services.
Our Advisory Services leverage Global Strategy Lab’s proven track record for developing scientific evidence to inform public policy and AMR governance. Combining the expertise of a university-affiliated research lab with a context-responsive policy consultancy allows us to provide fully customizable advisory offerings that are unique in the AMR policy world.
Our flexible, tailored approach supports policymakers navigating different stages in their own policy processes. Our Advisory Services are offered at a competitive price point with subsidized services available for low- and middle- income countries (LMICs).
Advisory offerings are built specific to policymakers’ timelines, available resources, and needs and can be scaled to provide solutions within 3-, 10-, 30-, 60-, and 90-day windows. Early-stage interventions include evidence synthesis, contextualized policy options, and SGBA+ and ethics reviews. Our later-stage interventions include our implementation and evaluation offerings.
Types of advisory support offered
Implementation & Evaluation
Ethics & Sex-and-gender-based analysis+
Convening Policy Dialogues
To discuss any of our services or other unique solutions to your policy needs: